AR and prostate carcinoma: By searching for pairs sense–antisense situated in androgen-regulated tag clusters that possess AR (androgen receptor)-binding sites, the authors identified CTBP1-AS as an androgen-responsive lncRNA, whose expression is generally up-regulated in prostate cancer [52].